Correlation Between Esperion Therapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on Esperion Therapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and ProMIS Neurosciences.
Diversification Opportunities for Esperion Therapeutics and ProMIS Neurosciences
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Esperion and ProMIS is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and ProMIS Neurosciences
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 0.98 times more return on investment than ProMIS Neurosciences. However, Esperion Therapeutics is 1.02 times less risky than ProMIS Neurosciences. It trades about 0.0 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.05 per unit of risk. If you would invest 228.00 in Esperion Therapeutics on December 2, 2024 and sell it today you would lose (58.00) from holding Esperion Therapeutics or give up 25.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Esperion Therapeutics vs. ProMIS Neurosciences
Performance |
Timeline |
Esperion Therapeutics |
ProMIS Neurosciences |
Esperion Therapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Esperion Therapeutics and ProMIS Neurosciences
The main advantage of trading using opposite Esperion Therapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. ANI Pharmaceuticals | Esperion Therapeutics vs. Phibro Animal Health |
ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |